Literature DB >> 2168997

Myristylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells.

C R Erdie1, J W Wills.   

Abstract

Rous sarcoma virus is an example of a replication-competent retrovirus whose Gag protein is not modified with myristic acid. The purpose of the experiments described in this report was to determine whether the addition of this 14-carbon fatty acid would interfere with the replication of Rous sarcoma virus. We found that myristylated derivatives of the Rous sarcoma virus Gag protein are fully functional for particle formation in avian cells and that the addition of myristic acid has very little effect on infectivity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168997      PMCID: PMC248019          DOI: 10.1128/JVI.64.10.5204-5208.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Site-directed mutagenesis of the gag-myc gene of avian myelocytomatosis virus 29: biological activity and intracellular localization of structurally altered proteins.

Authors:  M L Heaney; J Pierce; J T Parsons
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

2.  Mechanism of transfection of chicken embryo fibroblasts by Rous sarcoma virus DNA.

Authors:  G M Cooper; S Okenquist
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

3.  Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus.

Authors:  A Rein; M R McClure; N R Rice; R B Luftig; A M Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Fatty acylation of cellular proteins. Temporal and subcellular differences between palmitate and myristate acylation.

Authors:  E N Olson; G Spizz
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

Review 5.  Synthesis and processing of avian sarcoma retrovirus RNA.

Authors:  C M Stoltzfus
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

6.  Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification.

Authors:  L E Henderson; H C Krutzsch; S Oroszlan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  Purification and chemical and immunological characterization of avian reticuloendotheliosis virus gag-gene-encoded structural proteins.

Authors:  W P Tsai; T D Copeland; S Oroszlan
Journal:  Virology       Date:  1985-01-30       Impact factor: 3.616

8.  An N-terminal peptide from p60src can direct myristylation and plasma membrane localization when fused to heterologous proteins.

Authors:  D Pellman; E A Garber; F R Cross; H Hanafusa
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

9.  Avian sarcoma virus gag precursor polypeptide is not processed in mammalian cells.

Authors:  V M Vogt; D A Bruckenstein; A P Bell
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

10.  In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid.

Authors:  A M Schultz; S Oroszlan
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

View more
  22 in total

1.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src.

Authors:  J W Wills; R C Craven; R A Weldon; T D Nelle; C R Erdie
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.

Authors:  R C Craven; R P Bennett; J W Wills
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 4.  The structural biology of HIV assembly.

Authors:  Barbie K Ganser-Pornillos; Mark Yeager; Wesley I Sundquist
Journal:  Curr Opin Struct Biol       Date:  2008-04-09       Impact factor: 6.809

5.  A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity.

Authors:  T D Nelle; J W Wills
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  A single amino-acid substitution in gag p19 protein (MA) of Rous sarcoma virus suppresses virus production from infected cells.

Authors:  H Hara; A Kaji
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

7.  Intracellular trafficking of the UL11 tegument protein of herpes simplex virus type 1.

Authors:  J S Loomis; J B Bowzard; R J Courtney; J W Wills
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

8.  The membrane-binding domain of the Rous sarcoma virus Gag protein.

Authors:  M F Verderame; T D Nelle; J W Wills
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Conditions for copackaging rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding.

Authors:  R P Bennett; J W Wills
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release.

Authors:  R A Weldon; J W Wills
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.